Ignite Planners LLC Boosts Stake in Danaher Co. (NYSE:DHR)

Ignite Planners LLC lifted its position in Danaher Co. (NYSE:DHR) by 2.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,603 shares of the conglomerate’s stock after acquiring an additional 43 shares during the period. Ignite Planners LLC’s holdings in Danaher were worth $383,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Tsfg LLC lifted its position in shares of Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares in the last quarter. Cape Investment Advisory Inc. acquired a new stake in shares of Danaher in the fourth quarter valued at about $25,000. Redmont Wealth Advisors LLC purchased a new stake in shares of Danaher during the first quarter worth about $30,000. Wetzel Investment Advisors Inc. acquired a new position in shares of Danaher during the 4th quarter worth about $29,000. Finally, Rakuten Securities Inc. purchased a new position in Danaher in the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 9,600 shares of the firm’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total transaction of $2,641,536.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $5,566,486.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, CEO Rainer Blair sold 19,085 shares of Danaher stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $255.00, for a total value of $4,866,675.00. Following the completion of the transaction, the chief executive officer now directly owns 115,995 shares in the company, valued at $29,578,725. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Brian W. Ellis sold 9,600 shares of Danaher stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $5,566,486.80. The disclosure for this sale can be found here. Insiders sold a total of 66,797 shares of company stock worth $18,039,944 over the last three months. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on DHR shares. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and boosted their price target for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Royal Bank of Canada raised their price objective on Danaher from $297.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Bank of America increased their target price on shares of Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Finally, Evercore ISI decreased their price target on shares of Danaher from $266.00 to $260.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 2nd. Six analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $276.88.

Danaher Trading Down 0.2 %

DHR traded down $0.53 during trading hours on Friday, reaching $268.11. The company’s stock had a trading volume of 2,017,772 shares, compared to its average volume of 2,898,902. The stock has a market cap of $198.59 billion, a PE ratio of 45.44, a P/E/G ratio of 4.62 and a beta of 0.83. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.04. The business’s 50-day moving average is $257.31 and its 200-day moving average is $252.28.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, beating the consensus estimate of $1.57 by $0.15. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The company’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.05 EPS. As a group, equities research analysts predict that Danaher Co. will post 7.59 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.